2-166012254-C-T
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PP2PP3_ModeratePP5_Very_Strong
The NM_001165963.4(SCN1A):c.3734G>A(p.Arg1245Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000435 in 1,609,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.3734G>A | p.Arg1245Gln | missense_variant | Exon 22 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.3734G>A | p.Arg1245Gln | missense_variant | Exon 21 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.3701G>A | p.Arg1234Gln | missense_variant | Exon 19 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.3650G>A | p.Arg1217Gln | missense_variant | Exon 19 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes AF: 0.00000662 AC: 1AN: 151126Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1457874Hom.: 0 Cov.: 30 AF XY: 0.00000689 AC XY: 5AN XY: 725290
GnomAD4 genome AF: 0.00000662 AC: 1AN: 151126Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73814
ClinVar
Submissions by phenotype
Generalized epilepsy with febrile seizures plus, type 2 Pathogenic:2
The inherited c.3734G>A (p.Arg1245Gln) variant identified in the SCN1A gene substitutes a very well conserved Arginine for Glutamine at amino acid 1245/2010(exon 22/29). This variant is found with low frequency in gnomAD(v3.0) (1 heterozygote, 0 homozygotes; allele frequency: 6.62e-6) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms predict this variant to be Damaging (SIFT; score:0.001) and Pathogenic (REVEL; score: 0.808) to the function of the canonical transcript. This variant is reported as Pathogenic / Likely Pathogenic in ClinVar (VarID: 68533). The c.3734G>A (p.Arg1245Gln) variant identified here has been previously reported in several individuals in the literature with SCN1A associated epilepsy syndromes [PMID:17054684; PMID: 21906962; PMID: 28202706]. Given its low frequency in population databases, observation in several affected individuals in the literature, and in silico predictions of pathogenicity, the inherited c.3734G>A (p.Arg1245Gln) variant identified in the SCN1A gene is reported as Likely Pathogenic. -
- -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1245 of the SCN1A protein (p.Arg1245Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant severe myoclonic epilepsy of infancy (PMID: 17054684, 21906962, 28202706). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 68533). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SCN1A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Severe myoclonic epilepsy in infancy;C1858673:Generalized epilepsy with febrile seizures plus, type 2;C1864987:Migraine, familial hemiplegic, 3;C5543353:Developmental and epileptic encephalopathy 6B Pathogenic:1
PP3_Moderate+PM2_Supporting+PP2+PS4_Moderate+PM6_Supporting -
not provided Pathogenic:1
Identified in multiple patients with Dravet syndrome or other SCN1A-related epilepsy referred for genetic testing at GeneDx and in published literature (PMID: 28202706, 21906962, 36993157); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This substitution is predicted to be within the extracellular loop between the S1 and S2 transmembrane segments of the third homologous domain; This variant is associated with the following publications: (PMID: 18804930, 21906962, 17054684, 24331359, 32347949, 24136861, 17381446, 31440721, 36993157, 35074891, 28202706) -
Severe myoclonic epilepsy in infancy Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at